| 981/1816 | US=39 / Câncer Rosato RR, Grant S. Histone deacetylase inhibitors and anticancer activity. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 115-31. ISBN 978-1-58829-989-5. INIBIDORES HISTONA DEACETILASE; ATIVIDADE ANTICANCER; MECANISMO MOLECULAR; EPIGENETICA |
| 982/1816 | US=39 / Câncer Sorokin A. Eicosanoids and resistance of cancer cells to chemotherapeutic agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 133-56. ISBN 978-1-58829-989-5. EICOSANOIDES; RESISTENCIA DAS CELULAS CANCEROSAS; AGENTES QUIMIOTERAPEUTICOS; SINTESE CELULAR DE EICOSANOIDES; ACIDO ARAQUIDONICO |
| 983/1816 | US=39 / Câncer Chatterjee D, Sabo E, Resnick MB, Yeung KC, Chin YE. The RKIP and STAT3 axis in cancer chemotherapy: opposites attract. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 159-74. ISBN 978-1-58829-989-5. RKIP; STAT3; QUIMIOTERAPIA; CANCER; APOPTOSE; NF-KB; VIA JAK/STAT; RKIP |
| 984/1816 | US=39 / Câncer Gambari R. Targeting transcription factors with decoy oligonucleotideos: modulation of the expression of genes involved in chemotherapy resistance of tumor cells. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 175-87. ISBN 978-1-58829-989-5. FATORES DE TRANSCRICAO; OLIGONUCLEOTIDEOS DE ENGODO; MODULACAO DA EXPRESSAO DE GENES; RESISTENCIA A QUIMIOTERAPIA; CELULAS TUMORAIS |
| 985/1816 | US=39 / Câncer Maina F, Dono R. p53 inhibitors as cancer sensitizing agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 189-202. ISBN 978-1-58829-989-5. |
| 986/1816 | US=39 / Câncer Bonavida B, Huerta-Yepez S, Vega MI, Spandidos DA, Baritaki S. Nitric oxide-induced immunosensitization to apoptosis by Fas-L and TRAIL. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 203-10. ISBN 978-1-58829-989-5. |
| 987/1816 | US=39 / Câncer Jagetia G, Krishnan S, Aggarwal BB. Natural agents that can sensitize tumor cells to chemotherapy and radiation therapy. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 211-40. ISBN 978-1-58829-989-5. SENSIBILIZACAO DE CELULAS TUMORAIS; AGENTES NATURAIS; QUIMIOTERAPIA; TERAPIA POR RADIACAO; QUIMIORRESISTENCIA; RADIORESISTENCIA; POLIFENOIS RADIOSENSIVEIS |
| 988/1816 | US=39 / Câncer Johnson DE. Inhibitors of the Bcl-2 protein family as sensitizers to anticancer agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 243-61. ISBN 978-1-58829-989-5. INIBIDORES BCL-2; AGENTES ANTICANCERIGENOS; APOPTOSE; PEPTIDEOS BH3 |
| 989/1816 | US=39 / Câncer Wilson TR, Longley DB, Johnston PG. Therapeutic targeting of apoptosis in cancer. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 263-78. ISBN 978-1-58829-989-5. |
| 990/1816 | US=39 / Câncer Banerji S, Ande SR, Maddika S, Banerji V, Rashedi I, Owens NW, Zuse A, Schweizer F, Los M. Peptides and peptidomimetics as cancer therapy sensitizing agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 279-303. ISBN 978-1-58829-989-5. PEPTIDOS; PEPTIDOMIMETICOS; AGENTES SENSIBILIZANTES; TERAPIA DO CANCRO |
| 991/1816 | US=39 / Câncer Dings RPM, Klein M, Mayo KH. Non-peptidic mimetics as cancer-sensitizing agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 305-25. ISBN 978-1-58829-989-5. AGENTES SENSIBILIZADORES NAO-PEPTIDICOS MIMETICOS; CANCER; TERAPEUTICA DE COMBINACAO |
| 992/1816 | US=39 / Câncer Sarkar FH, Li Y. Sensitization of cancer cells to cancer therapies by isoflavone and its synthetic derivatives. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 327-35. ISBN 978-1-58829-989-5. SENSIBILIZACAO DAS CELULAS CANCEROSAS; TERAPIA DO CANCER; ISOFLAVONA; DERIVADOS SINTETICOS |
| 993/1816 | US=39 / Câncer Förster Y, Schwenzer B. Antisense oligonucleotides and siRNA as specific inhibitors of gene expression: mechanisms of action and therapeutic potential. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 337-62. ISBN 978-1-58829-989-5. OLIGONUCLEOTIDOS ANTI-SENTIDO; SIRNA COMO INIBIDORES ESPECIFICOS; EXPRESSAO DO GENE; MECANISMOS DE ACAO; POTENCIAL TERAPEUTICO |
| 994/1816 | US=39 / Câncer Efferth T, Wink M. DNA polymorphisms affecting chemosensitivity toward drugs. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 365-87. ISBN 978-1-58829-989-5. POLIMORFISMOS DE DNA; QUIMIOSENSIBILIDADE; DEFICIENCIA EM GLICOSE-6-FOSFATO DESIDROGENASE; CANCER |
| 995/1816 | US=39 / Câncer Cecchin E, Libra M, Cannavò C, Bruni B, Fulvi A, Toffoli G, Stivala F. Pharmacogenetics in cancer management: scenario for tailored therapy. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 389-403. ISBN 978-1-58829-989-5. CANCER. TERAPIA; FARMACOGENETICA; METABOLISMO DE FARMACOS; TRANSPORTE DE FARMACOS; MECANISMO DE ACAO DOS FARMACOS |
| 996/1816 | US=3-B / Clín/Médica Jameson JL, Kopp P. Princípios da genética humana. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison medicina interna. 17ª ed. Rio de Janeiro: McGraw-Hill, 2008. p. 385-406. ISBN 85-7726050-8. GENETICA HUMANA; EXPRESSAO GENETICA; MUTACOES; DOENCAS HEREDITARIAS |
| 997/1816 | US=3-B / Clín/Médica Walker DH, Dumler S, Marrie T. Riquetsioses. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison medicina interna. 17ª ed. Rio de Janeiro: McGraw-Hill, 2008. p. 1059-67. ISBN 85-7726050-8. RIQUETSIOSES; COCOBACILOS; FEBRE MACULOSA DAS MONTANHAS ROCHOSAS; FEBRES MACULOSAS TRANSMITIDAS POR CARRAPATOS; FEBRE TSUTSUGAMUSHI; ERLIQUIOSE; ANAPLASMOSE GRANULOCITOTROPICA HUMANA; FEBRE Q |
| 998/1816 | US=3-B / Clín/Médica Longo DL, Fauci AS. Retrovírus humanos. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison medicina interna. 17ª ed. Rio de Janeiro: McGraw-Hill, 2008. p. 1132-7. ISBN 85-7726050-8. RETROVIRUS HUMANOS; VIRUS LINFOTROPICO DE CELULAS T HUMANOS; INFECCAO PELO HTLV-I; VIRUS S IMUNODEFICIENCIA HUMANA |
| 999/1816 | US=3-B / Clín/Médica Fauci AS, Lane HC. Doença causada pelo vírus da imunodeficiência humana: AIDS e distúrbios relacionados. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison medicina interna. 17ª ed. Rio de Janeiro: McGraw-Hill, 2008. p. 1137-204. ISBN 85-7726050-8. VIRUS DA IMUNODEFICIENCIA HUMANA; AIDS; TRANSMISSAO HIV; RESPOSTA IMUNE HUMORAL; SINDROME AGUDA DO HIV |
| 1000/1816 | US=47 / Câncer Knudsen ES, Braden WA. RB-pathway: cell control and cancer therapy. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 1-17. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. VIA RB; CONTROLE DO CANCER; TERAPIA CELULAR; SUPRESSOR DE TUMOR; RETINOBLASTOMA; CICLINAS; QUIMIOTERAPIA; TERAPIA DE ALVO MOLECULAR; CICLO CELULAR; E2F; ANTIMETABOLITOS; AGENTES ANTIMICROTUBULOS |